[HTML][HTML] Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review

R Frood, C Burton, C Tsoumpas, AF Frangi… - European journal of …, 2021 - Springer
Purpose To systematically review the literature evaluating clinical utility of imaging metrics
derived from baseline fluorine-18 fluorodeoxyglucose positron emission …

[PDF][PDF] Radiomics in PET imaging: a practical guide for newcomers

F Orlhac, C Nioche, I Klyuzhin, A Rahmim, I Buvat - PET clinics, 2021 - Elsevier
Radiomic analysis of PET images is a promising approach to extract subtler information and
continuously evolves with advances in artificial intelligence. Using deep-learning methods …

[HTML][HTML] Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: international metabolic prognostic index

NG Mikhaeel, MW Heymans, JJ Eertink… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE Baseline metabolic tumor volume (MTV) is a promising biomarker in diffuse large
B-cell lymphoma (DLBCL). Our aims were to determine the best statistical relationship …

[HTML][HTML] 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma

JJ Eertink, T van de Brug, SE Wiegers… - European journal of …, 2022 - Springer
Purpose Accurate prognostic markers are urgently needed to identify diffuse large B-Cell
lymphoma (DLBCL) patients at high risk of progression or relapse. Our purpose was to …

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

L Vercellino, AS Cottereau… - Blood, The Journal …, 2020 - ashpublications.org
Early identification of ultra-risk diffuse large B-cell lymphoma (DLBCL) patients is needed to
aid stratification to innovative treatment. Previous studies suggested high baseline total …

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

JJ Eertink, GJC Zwezerijnen… - Blood, The Journal …, 2023 - ashpublications.org
The objective of this study is to externally validate the clinical positron emission tomography
(PET) model developed in the HOVON-84 trial and to compare the model performance of …

[HTML][HTML] Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT

AS Cottereau, M Meignan, C Nioche, N Capobianco… - Annals of …, 2021 - Elsevier
Background We analyzed the prognostic value of a new baseline positron emission
tomography (PET) parameter reflecting the spread of the disease, the largest distance …

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients

JJ Eertink, CN Burggraaff, MW Heymans… - Blood …, 2021 - ashpublications.org
Interim 18F-fluorodeoxyglucose positron emission tomography (Interim-18F-FDG-PET,
hereafter I-PET) has the potential to guide treatment of patients with diffuse large B-cell …

[HTML][HTML] Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features

JJ Eertink, GJC Zwezerijnen, MCF Cysouw… - European journal of …, 2022 - Springer
Purpose Biomarkers that can accurately predict outcome in DLBCL patients are urgently
needed. Radiomics features extracted from baseline [18F]-FDG PET/CT scans have shown …

Artificial intelligence in lymphoma PET imaging: a scoping review (current trends and future directions)

N Hasani, SS Paravastu, F Farhadi, F Yousefirizi… - PET clinics, 2022 - pet.theclinics.com
Artificial Intelligence in Lymphoma PET Imaging - PET Clinics Skip to Main Content
Advertisement PET Clinics Log in Register Log in Subscribe Claim Cart (1 item)1 Skip menu …